Intraoperative Autologous Blood Donation Leads to Fewer Transfusions in Cardiac Surgery

被引:18
|
作者
Zimmermann, Eric [1 ]
Zhu, Roger [1 ]
Ogami, Takuya [1 ]
Lamonica, Anthony [2 ]
Petrie, John A., III [2 ]
Mack, Charles [2 ]
Lang, Samuel [2 ]
Avgerinos, Dimitrios, V [2 ]
机构
[1] New York Presbyterian Queens, Dept Surg, 56-45 Main St,WLL 300, Flushing, NY 11355 USA
[2] New York Presbyterian, Dept Cardiothorac Surg, Weill Cornell Med, New York, NY USA
来源
ANNALS OF THORACIC SURGERY | 2019年 / 108卷 / 06期
基金
美国国家卫生研究院;
关键词
SYSTEMIC INFLAMMATORY RESPONSE; CARDIOPULMONARY BYPASS; THORACIC SURGEONS; CONSERVATION; HEMODILUTION; MORBIDITY; MORTALITY; SOCIETY; COST;
D O I
10.1016/j.athoracsur.2019.06.091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Blood conservation with antifibrinolytics, topical hemostatics, and strict transfusion triggers are becoming commonplace in cardiac surgery. The aim of this study was to evaluate the effect of a blood conservation protocol centering on standardized intraoperative autologous blood donation (IAD) use in cardiac surgery. Methods. We reviewed charts of patients who underwent cardiac surgery at our hospital over an 8-year period to analyze transfusion tendencies before and after a new blood conservation policy was implemented. Propensity score matching was used to account for population differences in preoperative and perioperative covariates. Results. Over an 8-year period (January 2009 to December 2017) 1002 patients were studied. Three hundred fifty-two patients before the new blood conservation policy (group 1) were compared with 650 patients after the change (group 2). Fewer group 2 patients required blood transfusions during their hospital stay (78% vs 61%, P <.001), were transfused fewer units (2.8 vs 1.81 units, P <.001), and experienced a shorter length of stay (8.02 vs 7.28 days, P = .012). Propensity score-matched cohorts revealed reductions in any complication (29.5% vs 18.8%, P = .007), fewer postoperative transfusions (70.1% vs 50.9%, P <.001), and a lower transfusion volume (1.82 vs 1.21 units, P =.002) associated with IAD without any associated change in mortality. Conclusions. IAD use is associated with reduced transfusions in cardiac surgery and may be considered a complementary aspect of blood conservation. Our experience suggests it may be applied with few limitations. A causal relationship between IAD and outcomes should be established with prospective studies. (C) 2019 by The Society of Thoracic Surgeons
引用
收藏
页码:1738 / 1744
页数:7
相关论文
共 50 条
  • [41] Should cardiac disease prevent autologous blood donation?
    McCarthy, LJ
    Danielson, C
    Pugh, M
    Skipworth, E
    Capello, W
    TRANSFUSION SCIENCE, 1997, 18 (01): : 81 - 83
  • [42] AUTOLOGOUS BLOOD DONATION IN TOTAL KNEE REPLACEMENT SURGERY
    MORRISSEY, DD
    ECKHOFF, DG
    ALONGI, CA
    CLINICAL RESEARCH, 1994, 42 (01): : A9 - A9
  • [43] Utilization of preoperative autologous blood donation in elective surgery
    Savoia, HF
    Metz, J
    Maxwell, EL
    Hauesler, MN
    Mellor, J
    Kiely, S
    ANZ JOURNAL OF SURGERY, 2002, 72 (08) : 557 - 560
  • [44] Autologous blood donation and epoetin alfa in cancer surgery
    Jeekel, J
    SEMINARS IN HEMATOLOGY, 1996, 33 (02) : 43 - 47
  • [45] Safety of autologous blood donation before cardial surgery
    Walpoth, BH
    Aregger, F
    Imboden, C
    Auckenthaler, E
    Nydegger, U
    Carrel, T
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2003, 38 (01): : 40 - 43
  • [46] Association of Intraoperative Red Blood Cell Transfusions With Venous Thromboembolism and Adverse Outcomes After Cardiac Surgery
    Raphael, Jacob
    Feng, Xiaoke
    Shotwell, Matthew S.
    Mazzeffi, Michael A.
    Bollen, Bruce A.
    Shah, Ashish S.
    Kertai, Miklos D.
    ANNALS OF SURGERY, 2023, 278 (03) : E650 - E660
  • [47] Cost Effectiveness of Epoetin-α to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery
    Douglas Coyle
    Karen M. Lee
    Dean A. Fergusson
    Andreas Laupacis
    PharmacoEconomics, 2000, 18 : 161 - 171
  • [48] Cost effectiveness of epoetin-α to augment preoperative autologous blood donation in elective cardiac surgery
    Coyle, D
    Lee, KM
    Fergusson, DA
    Laupacis, A
    PHARMACOECONOMICS, 2000, 18 (02) : 161 - 171
  • [49] Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery
    Walpoth, B
    Galliker, B
    Spirig, P
    Haeberli, A
    Rosenmund, A
    Althaus, U
    Nydegger, UE
    SEMINARS IN HEMATOLOGY, 1996, 33 (02) : 75 - 77
  • [50] The efficacy of predeposited autologous blood transfusions in general pediatric surgery
    Taguchi, T
    Suita, S
    Nakao, M
    Yamanouchi, T
    Inaba, S
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 2000, 30 (09): : 773 - 777